Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 32, 2003 - Issue 3
Submit an article Journal homepage
50
Views
34
CrossRef citations to date
0
Altmetric
Case report

Successful treatment of dermatomyositis‐related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine

C.C. Mok Department of Medicine, Tuen Mun Hospital, Hong KongCorrespondence[email protected]
,
C.H. To Department of Medicine, Tuen Mun Hospital, Hong Kong
&
M.L. Szeto Department of Medicine, Tuen Mun Hospital, Hong Kong
Pages 181-183 | Received 10 Oct 2002, Accepted 18 Mar 2003, Published online: 12 Jul 2009
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

Interstitial lung disease (ILD) is a major complication of idiopathic inflammatory myopathies (IIM). We report the successful use of oral cyclophosphamide, followed by azathioprine maintenance, in the treatment of a patient with dermatomyositis‐related rapidly deteriorating ILD, resistant to steroid. Prompt recognition and early aggressive immunosuppressive therapy may improve the outlook of this condition.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Clinical features of polymyositis/dermatomyositis with steroid-resistant interstitial lung disease.
Source: Japanese Society of Internal Medicine
Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
Source: Wiley
Management of cutaneous dermatomyositis
Source: Wiley
Dermatomyositis associated with rapidly progressive fatal interstitial pneumonitis and pneumomediastinum.
Source: Informa UK Limited
ILD in Anti-Jo-1 Patients
Source: Wiley
Pulse Intravenous Cyclophosphamide Treatment for Steroid-resistant Interstitial Pneumonitis Associated with Polymyositis
Source: Japanese Society of Internal Medicine
Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
Source: Springer Nature
Treatment in myositis
Source: Springer Science and Business Media LLC
Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens
Source: Wiley
Review of dermatomyositis: establishing the diagnosis and treatment algorithm.
Source: Informa UK Limited
Interstitial lung disease in polymyositis and dermatomyositis.
Source: Ovid Technologies (Wolters Kluwer Health)
Dermatomyositis: current and future treatments
Source: Informa UK Limited
Polymyositis-dermatomyositis-associated interstitial lung disease.
Source: American Thoracic Society

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.